| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.07 |